Aspergillus fumigatus contamination of lymphokine-activated killer cells infused into cancer patients
- 1 May 1991
- journal article
- case report
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 29 (5) , 1038-1041
- https://doi.org/10.1128/jcm.29.5.1038-1041.1991
Abstract
Lymphokine-activated killer (LAK) cells, prepared by incubating autologous lymphocytes in cell culture medium with interleukin-2, selectively lyse tumor cells and are effective immunotherapy of some cancers. During a 3-month period, two patients at our center were infused with LAK cells subsequently found to have been contaminated by Aspergillus fumigatus. Each case was investigated by obtaining environmental cultures and assessing aseptic practices during LAK cell preparation. Investigation of the first case demonstrated a malfunction of the laminar air flow hood, under which interleukin-2 and the patient's lymphocytes had been added to cell culture medium, and showed heavy A. fumigatus contamination of the hood, adjacent countertop, and cell culture incubator. Despite repair of the laminar air flow hood and cleaning of the laboratory, a second case occurred, and cultures at that time implicated the humidified cell culture incubators as the source of A. fumigatus. Following incubator sterilization and removal of the humidification apparatus from the incubators, weekly environmental cultures in the LAK cell laboratory were negative, and none of the LAK cell cultures from the 20 patients treated during the ensuing 15 months grew A. fumigatus. Our findings show that growth of fungi in humidified incubators, which previously has caused contamination problems in tissue culture and clinical microbiology laboratories, can result in patient infections when humidified incubators are used to prepare cells for reinfusion.Keywords
This publication has 10 references indexed in Scilit:
- An Acquired Chemotactic Defect in Neutrophils from Patients Receiving Interleukin-2 ImmunotherapyNew England Journal of Medicine, 1990
- Inadvertent intravenous infusion of Mucor during parenteral feeding of a neonate.1990
- An Outbreak of Hepatitis A among Cancer Patients Treated with Interleukin-2 and Lymphokine-Activated Killer CellsThe Journal of Infectious Diseases, 1990
- Some observations on contamination of animal cell cultures by the fungus Aspergillus fumigatus and suggested control measuresCell Biology International Reports, 1989
- Antigenemia in a Rabbit Model of Invasive AspergillosisThe Journal of Infectious Diseases, 1989
- Effect of Immunosuppression and Amphotericin B on Aspergillus Antigenemia in an Experimental ModelThe Journal of Infectious Diseases, 1988
- New Approaches to the Immunotherapy of Cancer Using Interleukin-2Annals of Internal Medicine, 1988
- Metastatic Renal Cancer Treated with Interleukin-2 and Lymphokine-Activated Killer CellsAnnals of Internal Medicine, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Fungi In Fluids--A Hazard Of Intravenous TherapyJournal of Medical Microbiology, 1970